11.06.2025

Proacta and Euvic to implement a project for the University Center for Women’s and Newborn Health

We are pleased to announce that the consortium of Proacta SA and Euvic SA has been selected through an open tender to implement a project for the University Center for Women's and Newborn Health of the Medical University of Warsaw sp. z o.o.

The project will be implemented as part of the initiative entitled “Ultra-early detection of precancerous and cancerous changes in digital colposcopy using artificial intelligence – an opportunity to improve prognosis and increase survival rates for patients with cervical cancer through effective diagnosis”.

As part of the task, the consortium will provide:

• 20 specialized research stations equipped with appropriate licenses,
• and will create a modern Central Information System (CSI) supporting colposcopic analysis using artificial intelligence.

The value of the contract is PLN 6,826,500.00, of which as much as 98% will go to Proacta SA. The contract will be implemented within 270 days from the date of signing.

This is another step towards the use of the latest technologies in medicine and confirmation of Proacta SA's competence in creating IT solutions for the healthcare sector. The project has the potential to have a real impact on the effectiveness of cervical cancer diagnosis and improve the prognosis for patients across the country.